These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36278620)

  • 21. Clinic-based infant screening for duchenne muscular dystrophy: a feasibility study.
    Cyrus A; Street N; Quary S; Kable J; Kenneson A; Fernhoff P
    PLoS Curr; 2012 May; 4():e4f99c5654147a. PubMed ID: 22866242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based path to newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Shilling C; Leslie ND; Flanigan KM; al-Dahhak R; Gastier-Foster J; Kneile K; Dunn DM; Duval B; Aoyagi A; Hamil C; Mahmoud M; Roush K; Bird L; Rankin C; Lilly H; Street N; Chandrasekar R; Weiss RB
    Ann Neurol; 2012 Mar; 71(3):304-13. PubMed ID: 22451200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis newborn screening: a model for neuromuscular disease screening?
    Scully MA; Farrell PM; Ciafaloni E; Griggs RC; Kwon JM
    Ann Neurol; 2015 Feb; 77(2):189-97. PubMed ID: 25425541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.
    Ross LF; Clarke AJ
    Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Framing optional genetic testing in the context of mandatory newborn screening tests.
    Lillie SE; Tarini BA; Janz NK; Zikmund-Fisher BJ
    BMC Med Inform Decis Mak; 2015 Jun; 15():50. PubMed ID: 26123051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study.
    Crossnohere NL; Armstrong N; Fischer R; Bridges JFP
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):169-177. PubMed ID: 35943031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
    Hildes E; Jacobs HK; Cameron A; Seshia SS; Booth F; Evans JA; Wrogemann K; Greenberg CR
    J Med Genet; 1993 Aug; 30(8):670-4. PubMed ID: 8411054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States.
    Thayer S; Bell C; McDonald CM
    J Manag Care Spec Pharm; 2017 Jun; 23(6):633-641. PubMed ID: 28530521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
    Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
    BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP
    Timonen A; Lloyd-Puryear M; Hougaard DM; Meriö L; Mäkinen P; Laitala V; Pölönen T; Skogstrand K; Kennedy A; Airenne S; Polari H; Korpimäki T
    Int J Neonatal Screen; 2019 Sep; 5(3):27. PubMed ID: 33072986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
    West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
    J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy.
    Beckers P; Caberg JH; Dideberg V; Dangouloff T; den Dunnen JT; Bours V; Servais L; Boemer F
    Sci Rep; 2021 Feb; 11(1):3011. PubMed ID: 33542429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities.
    Kumar SH; Athimoolam K; Suraj M; Das Christu Das MS; Muralidharan A; Jeyam D; Ashokan J; Karthikeyan P; Krishna R; Khanna-Gupta A; Bremadesam Raman L
    PLoS One; 2020; 15(6):e0232654. PubMed ID: 32559196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).
    Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L
    Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.